Abstract Details

Title Real-Life Use of OnabotulinumtoxinA for the Symptomatic Treatment of Chronic Migraine: The REPOSE Study

Topic Headache

Presentation(s) P4 - (-)

Poster/Presentation
Number 150

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Fayyaz Ahmed, MD, FRCP (Hull Royal Infirmary) PRESENTER	Dr. Ahmed has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for allergan.
	No disclosure on file
	No disclosure on file
Juan C. Garcia Monco Carra, MD, FAAN (Hospital De Basurto, Servicio De Neurologia)	Dr. Garcia Monco Carra has nothing to disclose.
Aubrey Adams, PhD	Dr. Manack Adams has received personal compensation for serving as an employee of Abbvie. Dr. Manack Adams has stock in Abbvie.

��ɫ����